Basic Information
RNALocate ID: | RLID:11001777 |
RNA Symbol: | hsa-miR-142-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-142-5p |
RNA ID: | miRBase:MIMAT0000433 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21505438 |
Tissue/Cell Line: | Primary dendritic cells|T cell line (J77) |
Method: | Microarray |
Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001785 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
RLID:11001776 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
RLID:11001778 | Exosome | Renal cancer cells | 21670082 |
RLID:11001779 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
RLID:11001780 | Exosome | Breast milk | 22211110 |
RLID:11001781 | Exosome | Brain tissue | 23382797 |
RLID:11001782 | Exosome | Plasma | 23663360 |
RLID:11001783 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001785 | Microvesicle | Liver resident stem cells | 20668554 |
RLID:11001786 | Microvesicle | Plasma | 23077538 |
RLID-D:11000083 | Exosome | Blood|B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells | |
RLID-D:11000361 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-142-5p | Mantle cell lymphoma | MNDR-E-MI-14022 |
MNDR | hsa-miR-142-5p | Splenic marginal zone lymphoma | MNDR-E-MI-14023 |
MNDR | hsa-miR-142-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-14024 |
MNDR | hsa-miR-142-5p | Oral squamous cell carcinoma | MNDR-E-MI-14025 |
MNDR | hsa-miR-142-5p | Medulloblastoma | MNDR-E-MI-14026 |
MNDR | hsa-miR-142-5p | Malt lymphoma | MNDR-E-MI-14027 |
MNDR | hsa-miR-142-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-14028 |
MNDR | hsa-miR-142-5p | Lymphoma | MNDR-E-MI-14029 |
MNDR | hsa-miR-142-5p | Lymphoma non-hodgkin | MNDR-E-MI-14030 |
MNDR | hsa-miR-142-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-14031 |
MNDR | hsa-miR-142-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-14032 |
MNDR | hsa-miR-142-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-14033 |
MNDR | hsa-miR-142-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-14034 |
MNDR | hsa-miR-142-5p | Her2-receptor positive breast cancer | MNDR-E-MI-14035 |
MNDR | hsa-miR-142-5p | Breast cancer luminal | MNDR-E-MI-14036 |
MNDR | hsa-miR-142-5p | Lupus nephritis | MNDR-E-MI-14037 |
MNDR | hsa-miR-142-5p | Dermatomyositis | MNDR-E-MI-14038 |
MNDR | hsa-miR-142-5p | Prostate cancer | MNDR-E-MI-14039 |
MNDR | hsa-miR-142-5p | Hirschsprung disease | MNDR-E-MI-14040 |
MNDR | hsa-miR-142-5p | Gastric lymphoma | MNDR-E-MI-14041 |
MNDR | hsa-miR-142-5p | Alzheimer disease | MNDR-E-MI-14042 |
MNDR | hsa-miR-142-5p | Intracranial aneurysm | MNDR-E-MI-14043 |
MNDR | hsa-miR-142-5p | Esophageal carcinoma | MNDR-E-MI-14044 |
MNDR | hsa-miR-142-5p | Head and neck cancer | MNDR-E-MI-14045 |
MNDR | hsa-miR-142-5p | Malaria | MNDR-E-MI-14046 |
MNDR | hsa-miR-142-5p | Leukemia | MNDR-E-MI-14047 |
MNDR | hsa-miR-142-5p | Huntington disease | MNDR-E-MI-14048 |
MNDR | hsa-miR-142-5p | Chorea | MNDR-E-MI-14049 |
MNDR | hsa-miR-142-5p | Cardiovascular disease | MNDR-E-MI-14050 |
MNDR | hsa-miR-142-5p | Lung cancer | MNDR-E-MI-14051 |
MNDR | hsa-miR-142-5p | Parkinson disease | MNDR-E-MI-14052 |
MNDR | hsa-miR-142-5p | Machado-joseph disease | MNDR-E-MI-14053 |
MNDR | hsa-miR-142-5p | Basal-like breast cancer | MNDR-E-MI-14054 |
MNDR | hsa-miR-142-5p | Pancreatic cancer | MNDR-E-MI-14055 |
MNDR | hsa-miR-142-5p | Melanoma | MNDR-E-MI-14056 |
MNDR | hsa-miR-142-5p | Rectum adenocarcinoma | MNDR-E-MI-14057 |
MNDR | hsa-miR-142-5p | Nephroblastoma | MNDR-E-MI-14058 |
MNDR | hsa-miR-142-5p | Colon cancer | MNDR-E-MI-14059 |
MNDR | hsa-miR-142-5p | Colon adenocarcinoma | MNDR-E-MI-14060 |
MNDR | hsa-miR-142-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-14061 |
MNDR | hsa-miR-142-5p | Familial ovarian cancer | MNDR-E-MI-14062 |
MNDR | hsa-miR-142-5p | Carcinoma ductal breast | MNDR-E-MI-14063 |
MNDR | hsa-miR-142-5p | Glioblastoma | MNDR-E-MI-14064 |
MNDR | hsa-miR-142-5p | Malignant glioma | MNDR-E-MI-14065 |
MNDR | hsa-miR-142-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-14066 |
MNDR | hsa-miR-142-5p | Osteosarcoma | MNDR-E-MI-14067 |
MNDR | hsa-miR-142-5p | Inclusion body myositis | MNDR-E-MI-14068 |
MNDR | hsa-miR-142-5p | Breast carcinoma | MNDR-E-MI-14069 |
MNDR | hsa-miR-142-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-14070 |
MNDR | hsa-miR-142-5p | Meningioma | MNDR-E-MI-14071 |
MNDR | hsa-miR-142-5p | Uterine cancer | MNDR-E-MI-14072 |
MNDR | hsa-miR-142-5p | Gastric adenocarcinoma | MNDR-E-MI-14073 |
MNDR | hsa-miR-142-5p | Cervical squamous cell carcinoma | MNDR-E-MI-14074 |
MNDR | hsa-miR-142-5p | Lung squamous cell carcinoma | MNDR-E-MI-14075 |
MNDR | hsa-miR-142-5p | Non-small cell lung cancer | MNDR-E-MI-14076 |
MNDR | hsa-miR-142-5p | Lung adenocarcinoma | MNDR-E-MI-14077 |
MNDR | hsa-miR-142-5p | Adrenocortical carcinoma | MNDR-E-MI-14078 |
MNDR | hsa-miR-142-5p | Thyroid carcinoma | MNDR-E-MI-14079 |
MNDR | hsa-miR-142-5p | Pancreatic adenocarcinoma | MNDR-E-MI-14080 |
MNDR | hsa-miR-142-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-14081 |
MNDR | hsa-miR-142-5p | Carcinoma renal cell | MNDR-E-MI-14082 |
MNDR | hsa-miR-142-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-14083 |
MNDR | hsa-miR-142-5p | Clear cell renal cell cancer | MNDR-E-MI-14084 |
MNDR | hsa-miR-142-5p | Cholangiocarcinoma | MNDR-E-MI-14085 |
MNDR | hsa-miR-142-5p | Esophageal cancer | MNDR-E-MI-14086 |
MNDR | hsa-miR-142-5p | Lung small cell carcinoma | MNDR-E-MI-14087 |
MNDR | hsa-miR-142-5p | Testicular germ cell cancer | MNDR-E-MI-14088 |
MNDR | hsa-miR-142-5p | Kidney diseases | MNDR-E-MI-14089 |
MNDR | hsa-miR-142-5p | Breast invasive carcinoma | MNDR-E-MI-14090 |
MNDR | hsa-miR-142-5p | Hepatocellular carcinoma | MNDR-E-MI-14091 |
MNDR | hsa-miR-142-5p | Familiar ovarian carcinoma | MNDR-E-MI-14092 |
MNDR | hsa-miR-142-5p | B-cell lymphoma | MNDR-E-MI-14093 |
MNDR | hsa-miR-142-5p | Rheumatoid arthritis | MNDR-E-MI-14094 |
MNDR | hsa-miR-142-5p | T-cell leukemia | MNDR-E-MI-14095 |
MNDR | hsa-miR-142-5p | Retinoblastoma | MNDR-E-MI-14096 |
MNDR | hsa-miR-142-5p | Barrett's adenocarcinoma | MNDR-E-MI-14097 |
MNDR | hsa-miR-142-5p | Chronic fatigue syndrome | MNDR-E-MI-14098 |
MNDR | hsa-miR-142-5p | Hodgkin lymphoma | MNDR-E-MI-14099 |
MNDR | hsa-miR-142-5p | Ulcerative colitis | MNDR-E-MI-14100 |
MNDR | hsa-miR-142-5p | Burkitt lymphoma | MNDR-E-MI-14101 |
MNDR | hsa-miR-142-5p | Dementia vascular | MNDR-E-MI-14102 |
MNDR | hsa-miR-142-5p | Tonsil cancer | MNDR-E-MI-14103 |
MNDR | hsa-miR-142-5p | Neuromyelitis optica | MNDR-E-MI-14104 |
MNDR | hsa-miR-142-5p | Skin cutaneous melanoma | MNDR-E-MI-14105 |
MNDR | hsa-miR-142-5p | Skin melanoma | MNDR-E-MI-14106 |
MNDR | hsa-miR-142-5p | Acute myeloid leukemia | MNDR-E-MI-14107 |
MNDR | hsa-miR-142-5p | Colorectal cancer | MNDR-E-MI-14108 |
MNDR | hsa-miR-142-5p | Nasopharynx carcinoma | MNDR-E-MI-14109 |
MNDR | hsa-miR-142-5p | Multiple myeloma | MNDR-E-MI-14110 |
MNDR | hsa-miR-142-5p | Fever | MNDR-E-MI-14111 |
MNDR | hsa-miR-142-5p | Cardiac hypertrophy | MNDR-E-MI-14112 |
MNDR | hsa-miR-142-5p | Nasopharyngeal cancer | MNDR-E-MI-14113 |
MNDR | hsa-miR-142-5p | Aids dementia complex | MNDR-E-MI-14114 |
MNDR | hsa-miR-142-5p | Stroke lacunar | MNDR-E-MI-14115 |
MNDR | hsa-miR-142-5p | Barrett's carcinogenesis | MNDR-E-MI-14116 |
MNDR | hsa-miR-142-5p | Breast cancer her3+ negative | MNDR-E-MI-14117 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AGER | Homo sapiens | RR00054545 |
TOP